⌘K

Home/Filings/4/0001127602-21-031134

4//SEC Filing

Babu Yarlagadda S 4

Accession 0001127602-21-031134

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 5:09 PM ET

Size

6.8 KB

Accession

0001127602-21-031134

Insider Transaction Report

Form 4

Period: 2021-12-14

BIOCRYST PHARMACEUTICALS INCBCRX

Babu Yarlagadda S

VP Drug Discovery

Transactions

Award
Common Stock
2021-12-14+35,000→ 250,056 total
Award
Emp. Stock Option (Right to Buy)
2021-12-14+164,000→ 164,000 total
Exercise: $11.43From: 2022-12-14Exp: 2031-12-14→ Common Stock (164,000 underlying)

Footnotes (2)

[F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
[F2]Annual Employee Option Grant becomes exercisable at the rate of 25% of each of the first, second, third and fourth anniversaries of the date of grant.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001452635

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 5:09 PM ET
Size: 6.8 KB

View on SEC.gov